GLP-1s are being tested for uses beyond weight loss and diabetes
Slimming syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Image…
Health
Discover the Latest Health, Medicine, Nutrition, and Fitness Tips for Women, Men, and Children
GEHC gives reasons to look beyond China's temporary woes and stocks rise again
GE Healthcare reported a mixed second quarter on Wednesday morning, and shares initially dipped sharply. Shares then reversed higher as…
A bullish bet on major banks is lost in the rotation of technology stocks
Each weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a handy evening update, just in time for the…
Novo Nordisk's liraglutide GLP-1 may slow the progression of Alzheimer's
A box of the drug Victoza, manufactured by Novo Nordisk Pharmaceutical, sits on a pharmacy counter in Provo, Utah, January…
Neuralink rival Synchron offers thought control with Apple Vision Pro
Mark uses the Vision Pro with his BCI Courtesy of Synchron Neurotechnology startup Synchron announced Tuesday that it has connected…
Pfizer (PFE) Q2 2024 Results
Kena Betancur | Corbis News | Getty Images Pfizer on Tuesday reported second-quarter revenue and adjusted earnings that beat expectations…
'An endless nightmare' of death and destruction in Gaza, UN officials tell Security Council
Muhannad Hadi, the UN Deputy Special Coordinator for the Middle East Peace Process, and Antonia De Meo, Deputy Commissioner-General of…
We are encouraged by Abbott's stock performance, but discouraged by the moves at Honeywell
Every weekday, the CNBC Investment Club with Jim Cramer publishes Homestretch, a handy evening update, just in time for the…
Health care in Sudan 'hangs by a thread', UN warns
In a particularly heinous attack, a hospital located next to residential areas and a livestock market in North Darfur state…
These are the top pharmaceutical stocks selected by JPMorgan for its results
JPMorgan is eyeing some drugmakers ahead of their earnings reports as investors continue to sell shares of major technology companies.…